Suchergebnisse - "Lipka, Daniel B"

PubPharm (12)

1

Bis(1H-indol-2-yl)methanones are effective inhibitors of FLT3-ITD tyrosine kinase and partially overcome resistance to PKC412A in vitro

enthalten in: British journal of haematology | 2009

von Heidel, F. | Lipka, D. | Mirea, F. | +8

2

Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis

enthalten in: Acta haematologica | 2009

von Kreft, A. | Springer, E. | Lipka, D. | +1

3

The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia

enthalten in: Leukemia research | 2008

von Kasper, S. | Breitenbuecher, F. | Hoehn, Y. | +6

4

The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia

enthalten in: Leukemia research | 2008

von Kasper, S. | Breitenbuecher, F. | Hoehn, Y. | +6

5

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells

enthalten in: Molecular cancer therapeutics | 2008

von Lipka, D. | Hoffmann, L. | Heidel, F. | +8

6

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells

enthalten in: Molecular cancer therapeutics | 2008

von Lipka, D. | Hoffmann, L. | Heidel, F. | +8

7

The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia

enthalten in: Leukemia research | 2008

von Kasper, S. | Breitenbuecher, F. | Hoehn, Y. | +6

8

Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia

enthalten in: Thrombosis and haemostasis | 2007

von Heidel, F. | Lipka, D. | von Auer, C. | +3

9

Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2006

von Rücker, F. | Bullinger, L. | Schwaenen, C. | +13

CommentIn: J Clin Oncol. 2007 Mar 20;25(9):1151-2; author reply 1152-3. - PMID 17369586

10

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

enthalten in: Blood | 2006

von Fröhling, S. | Lipka, D. | Kayser, S. | +6